Groupe Berkem Unveils BiombalanceTM and Pineol® Premium, two Active Ingredients From Its New Nutraceutical Range
13 Mayo 2024 - 11:05AM
Business Wire
- Polyphenols, in particular OPCs1, extracted from upcycled
raw materials and recognized for their many benefits to human
health
- Demonstration of Groupe Berkem's proven expertise in plant
extraction and local sourcing of high-quality raw
materials
- Innovative range of five ingredients dedicated to the highly
dynamic dietary supplement market
- Presentation of the range on May 14 to 16, 2024 at the
Vitafoods trade show in Geneva, booth H254, hall 6
Regulatory News:
Groupe Berkem (Paris:ALKEM), a leading player in
bio-based chemistry (ISIN code: FR00140069V2 – Ticker:
ALKEM), unveils today Pineol® Premium and BiombalanceTM, from its
new range of premium ingredients for the Nutraceutical market.
Nathalie Lévy, Marketing Manager for Groupe Berkem's Health,
Beauty & Nutrition business area, stated: "The ingredients
making up our new nutraceutical range once again highlight Groupe
Berkem's ability to capitalize on its recognized know-how to
position itself in a fast-growing market. Our long-standing
expertise in scientific objectification and plant extraction,
particularly in pine bark and grape seeds, combined with our
commitment to continuous improvement in raw material sourcing,
ensures that we can offer to the market active ingredients that are
effective and recognized for their benefits to human health. Our
two flagship ingredients, BiombalanceTM and Pineol® Premium, are
perfect examples of this expertise. The recent strengthening of our
industrial base through the acquisition of Naturex Iberian Partners
in Spain lends further credibility to the unique value proposition
of our range for this strategic market.”
Based on Groupe Berkem's long-standing expertise in the
extraction of plant compounds, the nutraceutical range developed by
the Group meets the growing demand for naturalness in this
fast-growing global market. The dietary supplements market is
dominated by the United States, which accounted for over $62
billion in 2023, with estimated growth of 2.6%2. In Western Europe,
the dietary supplements market was estimated to worth €14.5 billion
in 2023 and is expected to grow by around 5% a year between now and
20283.
The plant extracts in this new range of Groupe Berkem are
rigorously selected, guaranteed allergen-free, gluten-free, kosher
and halal, and come from a French upcycling supply4. Extracted from
grape seeds, BiombalanceTM is an innovative ingredient for gut
health and microbiota modulation. Pineol® Premium is an extract of
Landes pine bark, high in OPCs, sourced and produced by the Group.
Its health benefits have been extensively studied and
demonstrated.
Three additional premium ingredients, with recognized virtues
for human health, also make up this innovative range, namely
Symint™, Mallowsym™ and Symthym™, respectively based on the
benefits of peppermint on digestive comfort, marshmallow root to
soothe the throat and thyme on breathing.
The launch of this new range follows on from the acquisition of
i.Bioceuticals in February 2023, which gave Groupe Berkem a
footprint in North America, the world's leading Nutraceutical
market. The recent acquisition of Naturex Iberian Partners,
Givaudan's industrial site in Valencia, Spain, is also
strengthening the Group's position in this strategic market by
significantly increasing the Group's plant extraction production
capacity.
VitafoodsTM Europe Show
Groupe Berkem will present its new range for the Nutraceutical
market on May 14-16, 2024, at Vitafoods in Geneva, on booth H254,
hall 6.
ABOUT GROUPE BERKEM
Founded in 1993 by Olivier Fahy, Chairman and Chief Executive
Officer, Groupe Berkem is a leading force in the bio-based
chemicals market. Its mission is to advance the environmental
transition of companies producing the chemicals used in everyday
life (Construction & Materials, Health, Beauty & Nutrition,
Hygiene & Protection, and Industry). By harnessing its
expertise in both plant extraction and innovative formulations,
Groupe Berkem has developed bio-based boosters—unique high-quality
bio-based solutions augmenting the performance of synthetic
molecules. Groupe Berkem achieved revenue of €51.9 million in 2023.
The Group has almost 200 employees working at its head office
(Blanquefort, Gironde) and 4 production facilities in Gardonne
(Dordogne), La Teste-de-Buch (Gironde), Chartres (Eure-et-Loir) and
Tonneins (Lot-et-Garonne).
Groupe Berkem has been listed on Euronext Growth Paris since
December 2021 (ISIN code: FR00140069V2 - ALKEM)
www.groupeberkem.com
1 Oligomeric ProanthoCyanidins 2 Nutrition Business Journal,
Supplement Business report, 2023 3 Actif magazine, May 2024 4 With
the exception of Mallowsym, sourced from Europe
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240513851899/en/
Groupe Berkem Olivier Fahy,
Chairman and CEO Anthony Labrugnas, Chief Financial Officer Tél. :
+33 (0)5 64 31 06 60 investisseurs@berkem.com
NewCap Investor Relations
Mathilde Bohin / Nicolas Fossiez Tél. : +33 (0)1 44 71 94 94
Berkem@newcap.eu
NewCap Media Relations
Nicolas Merigeau / Antoine Pacquier Tél. : +33 (0)1 44 71 94 94
Berkem@newcap.eu
Groupe Berkem (EU:ALKEM)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Groupe Berkem (EU:ALKEM)
Gráfica de Acción Histórica
De May 2023 a May 2024